Finasteride Rowex 5 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

finasteride rowex 5 mg film-coated tablets

rowex ltd - finasteride - film-coated tablet - 5 milligram(s) - testosterone-5-alpha reductase inhibitors; finasteride

FINASTERIDE tablet, film coated United States - English - NLM (National Library of Medicine)

finasteride tablet, film coated

atlantic biologicals corps - finasteride (unii: 57gno57u7g) (finasteride - unii:57gno57u7g) - finasteride 5 mg - finasteride tablets usp, 5 mg administered in combination with the alpha-blocker doxazosin is indicated to reduce the risk of symptomatic progression of bph (a confirmed ≥4 point increase in american urological association (aua) symptom score). finasteride is not approved for the prevention of prostate cancer. finasteride is contraindicated in the following: - hypersensitivity to any component of this medication. - pregnancy. finasteride use is contraindicated in women when they are or may potentially be pregnant. because of the ability of type ii 5α-reductase inhibitors to inhibit the conversion of testosterone to 5α-dihydrotestosterone (dht), finasteride may cause abnormalities of the external genitalia of a male fetus of a pregnant woman who receives finasteride. if this drug is used during pregnancy, or if pregnancy occurs while taking this drug, the pregnant woman should be apprised of the potential hazard to the male fetus. in female rats, low doses of finasteride administered during pregnancy have prod

FINASTERIDE tablet United States - English - NLM (National Library of Medicine)

finasteride tablet

hetero drugs limited - finasteride (unii: 57gno57u7g) (finasteride - unii:57gno57u7g) - finasteride 5 mg - finasteride tablets usp are not approved for the prevention of prostate cancer.